• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of the role of hematopoietic cells in the development and progression of liver cirrhosis due to NASH and establishment of new therapeutic targets.

Research Project

Project/Area Number 19K17404
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 53010:Gastroenterology-related
Research InstitutionUniversity of Miyazaki

Principal Investigator

Ozono Yoshinori  宮崎大学, 医学部, 助教 (20839394)

Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
KeywordsNASH / 肝硬変 / fibrocyte / CDAHFD / CD11b-DTR / fibroycyte / clodronate liposome / TET2 / 非アルコール性脂肪肝炎
Outline of Research at the Start

本研究では、血液細胞が肝線維化の進展や脂肪肝の発症に与える影響を明らかにし、肝硬変やNASHの新たな治療の標的になり得るかを明らかにする。1つ目に単球由来の細胞であるfibrocyteの肝線維化における役割を明らかにし、fibrocyteを標的とした治療モデルを作成する。2つ目にTET2の機能欠損が、脂肪肝、NASHの病態に影響を与えるかを検討し、血液細胞と脂肪肝の関連性を検討する。

Outline of Final Research Achievements

Carbon tetrachloride (CCl4: carbon tetrachloride)-induced liver fibrosis model mice were treated with clodronate liposomes (CL: clodronate liposome) to selectively eliminate monocytes. Although fibrocytes in the liver were reduced compared to the non-CL-treated group, the progression of liver fibrosis was not suppressed. Therefore, the contribution of fibrocyte to liver fibrosis in the CCl4-induced liver fibrosis model is considered to be small. In the future, we plan to examine whether the elimination of monocytes in the liver of NASH model mice also reduces fibrocyte in the liver and suppresses the progression of liver fibrosis.

Academic Significance and Societal Importance of the Research Achievements

本研究により、CCl4誘導肝線維化モデルにおいては、その線維化進展における単球由来fibrocyteの寄与は小さいものと考えられ、その線維化改善のためにはfibrocyte以外の細胞を治療標的とするのが妥当であると考えられた。ただし、NASHモデルに関しては、その線維化進展におけるfibrocyteの寄与の程度は解明されていないため、今後の追加研究が必要と考えられる。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (2 results)

All 2019

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (1 results) (of which Int'l Joint Research: 1 results)

  • [Journal Article] Monocyte-derived fibrocytes elimination had little contribution on liver fibrosis2019

    • Author(s)
      Ozono Yoshinori、Shide Kotaro、Toyoshima Fumiyo、Takaishi Yuuka、Tsuchimochi Mai、Kamiunten Ayako、Kameda Takuro、Nakamura Kenichi、Miike Tadashi、Kusumoto Kazunori、Iwakiri Hisayoshi、Hasuike Satoru、Nagata Kenji、Sawaguchi Akira、Shimoda Kazuya
    • Journal Title

      Hepatobiliary & Pancreatic Diseases International

      Volume: Epub ahead of print Issue: 4 Pages: 348-353

    • DOI

      10.1016/j.hbpd.2019.02.002

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Depletion of Neoplastic CD11b Positive Cells in Jak2V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis2019

    • Author(s)
      Kazuya Shimoda
    • Organizer
      2019 ASH Annual Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi